spacer
home > pmps > winter 2001 > in outsourcing - a new paradigm in supply chain management
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

In Outsourcing - A New Paradigm in Supply Chain Management

The leader of a large pharmaceutical company once asked the question: "How do pharmaceutical companies effectively integrate outsourcing partners into an already sub-optimised set of supply-chain processes?" Most pharmaceutical executives will agree that the pharmaceutical industry as a whole has not embraced 'operational excellence'. Their focus has been on the development of technology and new and innovative blockbuster drugs.

However, recent cost pressures, expiring patents and increased government regulations have changed the content of many boardroom discussions. Executive discussions have started to centre around effective planning, supplier partnerships, internal and external development and manufacturing excellence, and global distribution capabilities. In comparison with other industries, supply chain management in the pharmaceutical industry is still a relatively new concept.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Keith Clinkscales of PA Consulting Group
Keith Clinkscales is a Member of PA Consulting Group's management team, responsible for developing PA's global life sciences and technology business in North America. Keith has served as an industry professional and consultant in pharmaceutical and high-tech industries for more than 15 years and has particular expertise in the procurement and supply chain areas.

spacer
Keith Clinkscales
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway1.
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement